iCAD
$14.319876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$14.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.92 (+6.87%) As of 4:02 PM UTC today
Why Robinhood?
You can buy or sell iCAD and other stocks, options, and ETFs commission-free!
About ICAD
iCAD, Inc. Common Stock, also called iCAD, is a medical technology company, which engages in the provision cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment include image analysis and workflow products. The Cancer Therapy segment consists radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH. The listed name for ICAD is iCAD, Inc. Common Stock.
CEO
Michael S. Klein
Employees
138
Headquarters
Nashua, New Hampshire
Founded
1984
Market Cap
328.01M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
146.47K
High Today
$14.93
Low Today
$13.58
Open Price
$13.58
Volume
104.97K
52 Week High
$15.31
52 Week Low
$5.91
Collections
Analyst Ratings
100%
of 6 ratings
Buy
100%
Hold
0%
Sell
0%
ICAD Earnings
-$0.22
-$0.15
-$0.07
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 25, After Hours